食管癌放疗后严重心脏事件的发生率与发生时间
该研究基于479例食管癌患者的前瞻性数据库,分析调强放疗或质子束治疗后≥3级心脏事件的发生率、发生时间及长期生存。结果显示18%患者发生≥3级心脏事件,中位发生时间7个月,中位随访76个月;既存心脏病和放疗方式与事件显著相关,平均心脏剂量(尤其<15 Gy)与减少事件相关,且≥3级心脏事件与更差总生存相关。
要点
- 食管癌放疗后≥3级心脏事件发生率为18%,中位发生时间7个月。
- 既存心脏病和调强放疗(对比质子束治疗)与≥3级心脏事件显著相关。
- ≥3级心脏事件与更差总生存显著相关(p=0.041)。
核心结论
- 食管癌放疗后严重心脏事件相对常见且发生较早,尤其见于既存心脏病和心脏受量较高的患者。
- 应优化治疗策略以降低心脏累积剂量,尤其对既存心脏病患者。
研究设计与样本
- 回顾性分析2005年3月至2017年8月MD Anderson癌症中心前瞻性维护数据库中479例食管癌患者。
- 所有患者接受调强放疗或质子束治疗,术前或根治性放疗。
- 聚焦依据CTCAE v5.0定义的≥3级心脏事件。
主要发现
- ≥3级心脏事件发生于18%的患者,中位发生时间7个月,中位随访76个月。
- 既存心脏病(p=0.001)和放疗方式(调强放疗对比质子束治疗,p=0.027)与≥3级心脏事件显著相关。
- 多变量分析中,平均心脏剂量(尤其<15 Gy)与减少≥3级事件相关。
- ≥3级心脏事件与更差总生存相关(p=0.041)。
临床怎么用
- 对食管癌放疗患者应关注既存心脏病史并优化放疗计划以降低心脏剂量。
- 考虑优先选择心脏剂量较低的治疗方式(如质子束治疗)以减少严重心脏事件。
局限性
- 研究为单中心回顾性分析,样本量479例。
- 未报告其他潜在混杂因素的具体控制情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Late cardiotoxicity related to radiotherapy (RT) in breast cancer and Hodgkin's lymphoma has been well-reported. However, the relatively higher cardiac dose exposure for esophageal cancer (EC) may result in the earlier onset of cardiac diseases. In this report, we examined the incidence, onset, and long-term survival outcomes of high-grade cardiac events after RT in a large cohort of patients with EC. METHODS: Between March 2005 and August 2017, a total of 479 patients with EC from a prospectively maintained institutional database at The University of Texas MD Anderson Cancer Center were analyzed. All patients were treated with either intensity-modulated RT or proton beam therapy, either preoperatively or definitively. We focused on any grade 3 or higher (G3+) cardiac events according to the Common Terminology Criteria for Adverse Events, version 5.0. RESULTS: G3+ cardiac events occurred in 18% of patients at a median of 7 months with a median follow-up time of 76 months. Preexisting cardiac disease (p = 0.001) and radiation modality (intensity-modulated RT versus proton beam therapy) (p = 0.027) were significantly associated with G3+ cardiac events. Under multivariable analysis, the mean heart dose, particularly of less than 15 Gy, was associated with reduced G3+ events. Furthermore, G3+ cardiac events were associated with worse overall survival (p = 0.041). CONCLUSIONS: Severe cardiac events were relatively common in patients with early onset EC after RT, especially those with preexisting cardiac disease and higher radiation doses to the heart. Optimal treatment approaches should be taken to reduce cumulative doses to the heart, especially for patients with preexisting cardiac disease.
引用
- Wang X, Palaskas NL, Yusuf SW, et al. Incidence and Onset of Severe Cardiac Events After Radiotherapy for Esophageal Cancer. J Thorac Oncol. 2020. PMID: 32599073. doi:10.1016/j.jtho.2020.06.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。